Health
New partnership aims to advance predictive tests for multiple myeloma in Ireland – News-Medical.Net
By combining genomic testing and next generation sequencing technology, a new partnership led by RCSI researchers aims to advance predictive tests for multiple myeloma, the second most common blood cancer in Ireland.
By combining genomic testing and next generation sequencing technology, a new partnership led by RCSI researchers aims to advance predictive tests for multiple myeloma (MM), the second most common blood cancer in Ireland.
The study will be carried out at Beaumont Hospital Dublin and run through the Blood Cancer Network Ireland with several other cancer hospitals in Ireland participating. It represents a collaboration between RCSI University of Medicine and Health Sciences and SkylineDx with fun…
-
General18 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General21 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
Noosa News20 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
Business23 hours agoThese ASX 200 shares could rise 55% to 65%